Biosero to Deliver $15.2M Integrated Lab Automation Solutions for a Global Pharma Customer

Biosero has entered into a master service agreement with a global pharma customer, marking the start of an ambitious project to deliver integrated laboratory automation solutions worth $15.2 million.

The solutions will play a central role in the customer’s drug development process, powered by Biosero’s Green Button Go® software platform. This software enables seamless integration of diverse instruments and workflows, creating a connected technology ecosystem that helps accelerate research timelines and enhance productivity.

The project will run from September 2025 through the end of 2026. Early phases will focus on infrastructure and hardware, followed by ongoing delivery of software and automation services to support the customer’s innovation pipeline.

“This project shows the strength of our integrated lab automation portfolio and aligns perfectly with BICO’s mission to enable and automate the life science lab of the future. By combining our automation expertise with the customer’s innovative drug development, we are strengthening our long-term relationship and helping accelerate timelines and improve outcomes in critical research areas”, says Maria Forss, President and CEO of BICO.

This agreement highlights Biosero’s ongoing commitment to partnering with global leaders in life sciences to enable the lab of the future—where automation and science work hand in hand to address the world’s most critical needs.

For further information, please contact:

Maria Forss, President & CEO, BICO Group AB

Phone: EA Isabella Lundin +46 73 515 99 64

E-mail: mf@bico.com

Jacob Thordenberg, Chief Financial Officer, BICO Group AB

Phone: +46 73 534 88 84

E-mail: jt@bico.com

This information is information that BICO Group is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-09-05 00:05 CEST.

About BICO

BICO is a lab automation partner and provider of selected workflows to pharma and biotech. With 48,000+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 10,900 publications. Operating through two business areas – Lab Automation and Life Science Solutions – BICO strives towards the vision to enable and automate the life science lab of the future. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO. www.bico.com

About Biosero

Biosero, a member of the BICO group, develops science-centric software and laboratory automation solutions that enable researchers to orchestrate their discoveries at every stage. Biosero’s Green Button Go® Scheduler software and integration services match laboratory automation to science, creating a cohesive technology ecosystem that accelerates operations and increases productivity.

Additionally, Green Button Go Orchestrator applications provide an end-to-end laboratory management solution, directing workflows and operations in life science, biotechnology, pharmaceutical, and diagnostic research. Biosero is passionate about partnering with organizations dedicated to enhancing life by addressing the world’s most significant needs.

For more information, please visit www.biosero.com.